Latest News & Updates
Breaking News
19 hours ago
Vaibhavi M.
Other trending news you may like to read
Merck Completes Cash Tender Offer To Acquire Cidara Therapeutics In $221.50-Per-Share Deal
Merck finalizes the acquisition of Cidara Therapeutics, adding the long-acting antiviral CD388 to its pipeline.
Vaibhavi M.
Merck Initiates Phase 3 KANDLELIT-007 Trial Of Calderasib Plus KEYTRUDA QLEX In KRAS G12C NSCLC
Merck begins a global Phase 3 trial of calderasib with KEYTRUDA QLEX as first-line therapy for KRAS G12C NSCLC.
Vaibhavi M.
Monte Rosa Reports Positive Phase 1 Interim Data For NEK7 Degrader MRT-8102 In Inflammatory Diseases
Monte Rosa reports encouraging Phase 1 interim data for MRT-8102, an oral molecular glue degrader for inflammatory diseases.
Vaibhavi M.
Syndax Partners With World Orphan Drug Alliance To Expand Global Access To Revuforj Via Managed Access Program
Syndax collaborates with WODA to provide global patient access to Revuforj in regions where the therapy is not yet approved.
Vaibhavi M.
